Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

U24 Heptacarboxyporphyrin

Immunology & Autoimmune

24 hour urine heptacarboxylporphyrinU24 HeptaCPUrinary heptacarboxyl porphyrin, timed

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the amount of heptacarboxyporphyrin excreted in your urine over a full day. Heptacarboxyporphyrin is one of the porphyrins, natural chemicals your body uses to make heme, a key part of hemoglobin and many enzymes. When the heme pathway is disrupted, certain porphyrins build up and can spill into urine.

Your result helps map the pattern of porphyrins in urine, which can point toward specific types of porphyria or other liver-related conditions. The sample is a timed 24 hour urine collection that is typically protected from light and kept cool to preserve accuracy.

Why it matters

Clinicians use this test when they suspect a porphyria or to characterize a known porphyria, especially forms that affect the liver or skin. It helps distinguish among different types when combined with other porphyrin tests, symptoms, and examination findings.

Abnormal results can occur with porphyria cutanea tarda and other hepatic porphyrias, and may also be seen with liver disease, alcohol use, certain infections, or medication effects. Understanding your porphyrin pattern can guide treatment, monitoring, and counseling for you and your family.

Understanding your results

If your heptacarboxyporphyrin output is higher than expected, your clinician will consider the full porphyrin profile, your symptoms, and other lab findings. Follow up may include fractionated urine porphyrins, plasma fluorescence scanning, stool porphyrins, and sometimes genetic testing to confirm a specific type.

Normal or low findings are generally reassuring. Borderline or unexpected results may need a repeat collection with careful timing and handling. Always discuss results in the context of recent medications, alcohol intake, liver health, and any skin or abdominal symptoms you may have.

Reference ranges

-- nmol/d
All sexes
0 days – 16 years
06 nmol/d
All sexes
16 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact U24 Heptacarboxyporphyrin

  • Complete 24 hour collection

    Missing any urine during the collection period will lower the measured output and can mask an abnormal result. Start and end the collection as instructed and record the total time.

  • Light and temperature

    Porphyrins are light sensitive. Samples should be protected from light and kept cool during collection and transport to prevent degradation that may falsely lower results.

  • Medications and substances

    Drugs that affect liver enzymes, such as some anti-seizure medicines or rifampin, and alcohol can change porphyrin production. Tell your clinician about all prescriptions, supplements, and alcohol use.

  • Liver health

    Chronic liver disease, iron overload, and viral hepatitis can increase urinary porphyrins. Your clinician may interpret results alongside liver enzymes and iron studies.

  • Timing with symptoms

    Collecting during or soon after symptoms such as skin fragility, blistering, or abdominal pain can increase the chance of detecting abnormalities related to porphyria.

  • Pregnancy and hormones

    Hormonal changes, estrogen therapy, or pregnancy can influence porphyrin metabolism. Let your clinician know if you are pregnant or using hormonal medications.

  • Kidney function and hydration

    Severe kidney impairment or very low urine output can alter excretion patterns. Accurate timing and complete collection help mitigate these effects.

2026

References

  1. McGill University Health Centre. (2014, October 21). U24 Heptacarboxyporphyrin (Task CD 11380080). Laboratory reference ranges.
  2. European Association for the Study of the Liver. (2017). EASL Clinical Practice Guidelines on Porphyria. Journal of Hepatology, 66(2), 356-381.
  3. Balwani, M., & Desnick, R. J. (2012). The porphyrias: Advances in diagnosis and treatment. Blood, 120(23), 4496-4504.